CLDF Title
Contact Us | Bookmark
About CLDF Centers of Educational Expertise  
CME Dinner Meetings Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
Banner4 Banner2 Banner3
  Liver News - REUTERS   Congress Calendar   Physician Resources  
Nonalcoholic fatty liver disease linked to procoagulant imbalance
Costs to public of $84,000 hep C drug 'outrageous' - Kaiser
Gilead says has discounted hepatitis C drug for some health plans
Glycerol phenylbutyrate improves hepatic encephalopathy outcomes
View Complete News Library
June 4-7
20th Annual International Congress Of The International Liver Transplantation Society (ILTS)
London, UK
June 6-7
GALA (GI and Liver Association of the Americas) Conference
Dallas, Texas
June 9-12
47th Annual Meeting- The European Society For Pediatric Gastroenterolgy, Hepatology & Nutrition (ESPGHAN)
Jerusalem, Israel
July 26-31
American Transplant Congress
San Francisco, California
View all Congresses
  Featured Abstracts          
Second wave Anti-HCV Protease Inhibitors: Too little too late?
The Effect of Mild to Moderate Renal Impairment on the Pharmacokinetics of the Nucleoside Analog Hepatitis C Virus Polymerase Inhibitor Mericitabine
Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 12188)
Fracture risk in hepatitis C virus infected persons: results from the DANVIR cohort study
Barriers to HCV treatment in the era of triple therapy: A prospective multi-centered study in clinical practice
Hepatitis C treatment: an incipient therapeutic revolution
Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
Hepatitis B in pregnancy
Management of hepatitis B during pregnancy
Prevention of Neonatal Hepatitis B Virus Transmission
Survival in infection-related acute-on-chronic liver failure is defined by extra-hepatic organ failures
Cerebral Hemodynamics In Cirrhotic Patients With Hepatic Encephalopathy
Management of hyponatremia in clinical hepatology practice
Branched-chain amino acid supplementation in adults with cirrhosis and porto-systemic encephalopathy: Systematic review
Combination Therapy of Sorafenib and TACE for Unresectable HCC: A Systematic Review and Meta-Analysis
Alternative Response Criteria (Choi, European Association for the Study of the Liver, and Modified Response Evaluation Criteria in Solid Tumors [RECIST]) Versus RECIST 1.1 in Patients With Advanced Hepatocellular Carcinoma Treated With Sorafenib
Improved Survival Outcomes in Patients with Nonalcoholic Steatohepatitis and Alcoholic Liver Disease Following Liver Transplantation: An Analysis of 2002-2012 UNOS Data
Competing risks and prognostic stages of cirrhosis: a 25-year inception cohort study of 494 patients
          View All Abstracts  
Slide Library
Abstract Library
CME Dinner Meeting
Slide Library
Abstract Library
Slide Library
Abstract Library
Slide Library
Abstract Library
CLDF Follow Us
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
Centers of
Educational Expertise
Regional Map
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2014 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.